Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.
Liang K, Volk AG, Haug JS, Marshall SA, Woodfin AR, Bartom ET, Gilmore JM, Florens L, Washburn MP, Sullivan KD, Espinosa JM, Cannova J, Zhang J, Smith ER, Crispino JD, Shilatifard A.
Liang K, et al. Among authors: florens l.
Cell. 2017 Jan 12;168(1-2):59-72.e13. doi: 10.1016/j.cell.2016.12.011. Epub 2017 Jan 5.
Cell. 2017.
PMID: 28065413
Free PMC article.